期刊文献+

三种左心耳封堵器的初步植入经验 被引量:4

Transcatheter left atrial appendage closure:initial experience of implantation with three occluders
下载PDF
导出
摘要 目的介绍3种不同形态左心耳封堵器行经皮左心耳封堵术的初步植入经验。方法应用3种封堵器,对60例CHADS2评分≥1分且不适宜口服华法林钠长期抗凝的非瓣膜心房颤动患者行左心耳封堵术。借鉴现有封堵器的标准手术流程,探索新型国产双盘状LAmbre左心耳封堵器的植入方法,并拟应用Overlay技术改良新型国产Lefort和Watchman半球面封堵器的植入流程。封堵成功定义为封堵器周围无残余分流或轻微残余分流(残余分流直径<5mm)。结果 60例患者中,分别应用LAmbre左心耳封堵器54例,Watchman左心耳封堵器2例、Lefort左心耳封堵器4例,无残余分流51例、残余分流直径≤3mm 8例、残余分流直径为3.5mm 1例,提示均封堵成功。手术时间为(67.1±18.0)min,进鞘-出鞘时间为(42.6±16.6)min。封堵器更换10例共11次,平均释放(2.3±1.5)次。术中1例患者因径路损伤出血而输血,无其他严重不良事件发生。结论行左心耳封堵术中,应用LAmbre、Watchman、Lefort 3种左心耳封堵器植入均安全有效。 Objective To present initial experience of implantation with three devices for percutaneous left atrial appendage (LAA) closure. Methods Inclusion criteria of cases: patients had non-valvular atrial fibrillation with a CHADS2 score of at least 1 point and were not candidates for long-term anticoagulation with warfarin. Based on standard operation protocols of I_AA closure, we would like to explore the implantation of newly-designed domestic two-disc occluder named LAmbre. Overlay technique was used to improve implantation of newly-designed domestic semi-spherical occluders named Lefort and the Watchman. Successful occlusion was defined as no flow or slight residual (diameter of residual shunt less than 5 mm) around occlude. Results A total of 60 patients underwent percutaneous LAA closure in this study. Of them, L.Ambre was used in 54, Watchman in 2 and Lefort in 4. All procedures reached the criterion of LAA closure; there were 51 cases without flow and 9 cases with slight residual shunt (diameter≤3 mm in 8 and diameter was 3.5 mm in another one). The overall mean operation time was (67. 1± 18.0) min, and the time between insertion and extraction was (42.6 ± 16.6) min. Occluder was changed in 10 patients for 11 times with an average of 2.3± 1.5. Bloocl transfusion was performed in one case because of bleeding from pathway injury. But no severe adverse events occurred during the operation. Conclusion LAA closure with newly-designed domestic devices, LAmbre or Lefort and Watchman are safe and effective.
出处 《上海医学》 CAS CSCD 北大核心 2015年第3期189-192,F0003,共5页 Shanghai Medical Journal
关键词 心房颤动 经皮左心耳封堵术 封堵器 Atrial fibrillation Transcatheter left atrial appendage closure Occluder
  • 相关文献

参考文献9

  • 1FURBERG C D. PSATY B M. MANOLIO T A. et al. Prevalence of atrial fibrillation in elderly subjects (the cardiovascular health study)[J]. AmJ Cardiol , 1994. 74 (3): 236-24l.
  • 2OSTERMAYER S. RESCHKE M. BILLINGER K. et al. Percutaneous closure of the left atrial appendage[J].J Interv Cardiol , 2003. 16(6): 553-556.
  • 3FOUNTAIN R B. HOLMES D R. CHANDRASEKARAN K. et al. The Protect AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial[J]. Am HeartJ. 2006. 151(5): 956-96l.
  • 4HOLMES D R. REDDY V v. TURI Z G, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial[J]. Lancet, 2009. 374(9689): 534-542.
  • 5MORLEYJ. MARINCHAK R. RIALS SJ. et al. Atrial fibrillation, anticoagulation, and stroke[J]. AmJ Cardiol , 1996, 77(3): 38A-44A.
  • 6MOBIUS-WINKLER S. SCHULER G C, SICK P B. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the W atchman device[J]. Curr Opin Neurol , 2008. 21(1): 64-69.
  • 7HALPERINJ L. GOMBERG-MAITLAND M. Obliteration of the left atrial appendage for prevention of thromboembolism[J].J Am Coll Cardiol , 2003, 42 (7): 1259-1261.
  • 8ONALAN 0, CRYSTAL E. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation[J]. Stroke. 2007. 38(Suppl 2): 624-630.
  • 9LAM Y Y. YAN B p, DOSHI S K. et al. Preclinical evaluation of a new left atrial appendage occluder (Lifetech LAmbre device) in a canine model[J]. IntJ Cardiol , 2013, 168(4): 3996-4001.

同被引文献36

  • 1Colilla S,Crow A,Petkun W,et al.Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S.adult population[J].Am J Car- diol,2013,112:1142-1147.
  • 2European Heart Rhythm Association,European Association for Cardio-thoracic Surgery,Camm AJ,et al.Guidelines for the management of atrial fibrillation:the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)[J],Eur Heart J,2010,31:2369-2429.
  • 3Blackshear JL,Odell JA.Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation[J].Ann Thorac Surg,1996,61:755-759.
  • 4Veinot JP5Harrity PJ,Gentile F,et al.Anatomy of the normal left atrial append- age:a quantitative study of age-related changes in 500 autopsy hearts:implica- tions for echocardiographic examination[J].Circulation,1997,96:3112-3115.
  • 5di Biase L,Santangeli P,Anselmino M,et al.Does the left atrial appendage mor- phology correlate with the risk of stroke in patients with atrial fibrillation.Results from a multicenter study[J].J Am Coll Cardiol,2012,60:531-538.
  • 6Camm AJ,Lip GY,de Caterina R,et al.2012 focused update of the ESC guide- lines for the management of atrial fibrillation:an update of the 2010 ESC guide- lines for the management of atrial fibrillation[J].Eur Heart J,2012,33;2719-2747.
  • 7Ostermayer SH,Reisman M,Kramer PH,et al.Percutaneous left atrial append- age transcatheter occlusion(PLAATO system)to prevent stroke in high-risk pa- tients with nonrheumatic atrial fibrillation:results from the international multi- center feasibility trials[J].J Am Coll Cardiol,2005,46:9-14.
  • 8Bayard YL,Omran H,Neuzil P,et al.PLAATO(percutaneous left atrial ap- pendage transcatheter occlusion)for prevention of cardioembolic stroke in non- anticoagulation eligible atrial fibrillation patients:results from the European PLAATO study[J].Eurolntervention,2010,6:220-226.
  • 9Park JW,Bethencourt A,Sievert H,et al.Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation:initial European experience[J].Catheter Cardiovasc Interv,2011,77:700-706.
  • 10Urena M,Rodes-Cabau J,Freixa X,et al.Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy[J].J Am Coll Cardiol,2013,62:96-102.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部